00775.HK
CK Life Sciences Int'l., (Holdings) Inc.
HKSE · Healthcare · Biotechnology · HK
HKD 0.59
+0.85%Year over year
Reported trailing growth
- Revenue
- +3.0%
- EBITDA
- -89.1%
- EBIT
- -20.3%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -67.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +0.8%
- EBITDA
- —
- EBIT
- —
- Net income
- -48.9%
- EPS
- -47.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026